Compare · KBLM vs PDD
KBLM vs PDD
Side-by-side comparison of KBL Merger Corp. IV (KBLM) and PDD Holdings Inc. (PDD): market cap, price performance, sector, and recent activity on the wire.
Summary
- KBLM operates in Finance, while PDD operates in Consumer Discretionary - the two are in different parts of the market.
- PDD carries a market cap of $111.18B.
- PDD has hit the wire 2 times in the past 4 weeks while KBLM has been quiet.
- PDD has more recent analyst coverage (25 ratings vs 0 for KBLM).
- Company
- KBL Merger Corp. IV
- PDD Holdings Inc.
- Price
- -
- -
- Market cap
- -
- $111.18B
- 1M return
- -
- -3.52%
- 1Y return
- -
- -39.49%
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2017
- 2018
- News (4w)
- 0
- 2
- Recent ratings
- 0
- 25
PDD Holdings Inc.
Pinduoduo Inc., through its subsidiaries, operates an e-commerce platform in the People's Republic of China. It operates Pinduoduo, a mobile platform that offers a range of products, including apparel, shoes, bags, mother and childcare products, food and beverage, fresh produce, electronic appliances, furniture and household goods, cosmetics and other personal care items, sports and fitness items, and auto accessories. The company was formerly known as Walnut Street Group Holding Limited and changed its name to Pinduoduo Inc. in July 2018. Pinduoduo Inc. was incorporated in 2015 and is headquartered in Shanghai, the People's Republic of China.
Latest KBLM
- KBL Merger Corp. IV Announces Completion of Acquisition of 180 Life Sciences Corp. and Trading Under the ticker ATNF Starting November 9, 2020
- KBL Merger Corp. IV Announces Approval of Business Combination with 180 Life Sciences at the Special Meeting of Shareholders Held on November 5, 2020
- KBL Merger Corp. IV Announces Change of Special Meeting of Shareholders Date to November 5, 2020
- Innovative Companies with Blockbuster Potential Catch SPAC Attention
- In Pursuit of the Elusive Drug -- the Billion-Dollar Blockbuster
- UPDATE -- The Quest for Blockbuster Drugs Continues
- Blockbuster Year and Bright Horizons for SPACs
- Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
- Groundbreaking Studies Offer Hope for Unmet Medical Needs in Inflammatory Disease
- Solving One of the Largest Drivers of Disease: Inflammation
Latest PDD
- PDD Holdings to Report Third Quarter 2026 Unaudited Financial Results on November 19, 2026
- PDD Holdings downgraded by Morgan Stanley with a new price target
- PDD Holdings downgraded by Arete with a new price target
- Director Kam Anthony Ping Leung sold $140,151 worth of ADSs (1,705 units at $82.20), closing all direct ownership in the company (SEC Form 4)
- Director Kam Anthony Ping Leung converted options into 1,705 units of ADSs (SEC Form 4)
- SEC Form 6-K filed by PDD Holdings Inc.
- PDD Holdings Announces Second Quarter 2026 Unaudited Financial Results
- SEC Form 6-K filed by PDD Holdings Inc.
- PDD Holdings to Report Second Quarter 2026 Unaudited Financial Results on August 24, 2026
- Director Yeo George Yong-Boon converted options into 1,584 units of ADSs, increasing direct ownership by 6% to 27,212 units (SEC Form 4)